Table 2. Mean changes in QoL scores among 161 Danish prostate cancer survivors included in a randomised rehabilitation study, Odense, Denmark.
| Effect (coefficient)a | CI (95%) | Pb | |
|---|---|---|---|
|
Intervention group vs control group | |||
|
SF-12 | |||
| Physical QoL (PCS) | 3.6 | 1.3; 5.8 | 0.002 |
| Mental QoL (MCS) |
0.7 |
−1.6; 3.0 |
0.549 |
|
EPIC domains | |||
| Urinary | 4.5 | 0.6; 8.4 | 0.023 |
| Incontinence | 2.6 | −1.8; 6.9 | 0.242 |
| Irritative | 5.8c | 1.4; 10.3 | 0.011 |
| Bowel | 3.0 | −1.9; 8.0 | 0.224 |
| Sexual | 3.6 | −0.9; 8.0 | 0.117 |
| Hormonal | 4.8 | 0.8; 8.8 | 0.018 |
Abbreviations: CI=95% confidence interval; EPIC=Expanded Prostate Cancer Index Composite; MCS=Mental Component Summary; PCS=Physical Component Summary; QoL=quality of life.
a
Multiple linear regression analysis adjusted for pre-intervention scores.
b
Reported P-values are two-sided and P<0.05 was considered statistically significant.
c
Example: if the patient is in the intervention group, his mean QoL score (0–100 scale) regarding urinary irritative sum-score increases with 5.8 point compared with the controls.